BioCentury | Apr 27, 2018
Finance

Revolution revamp

...year, hired Stephen Kelsey as president of R&D. Kelsey was president of oncology mRNA play Onkaido Therapeutics LLC...
BioCentury | Sep 14, 2017
Company News

Moderna unveils organizational changes and new candidates

...heart failure patients undergoing coronary artery bypass grafting (CABG) surgery. Mary Romeo AZD-8601 mRNA-2416 Alexion Pharmaceuticals Inc. CRISPR Therapeutics AG Elpidera LLC Onkaido Therapeutics LLC Valera...
BioCentury | Mar 21, 2017
Company News

Management tracks

...Medicines Inc. (Redwood City, Calif.) named Stephen Kelsey president of R&D. Kelsey was president of Onkaido Therapeutics LLC...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, AstraZeneca deal

...develop and co-commercialize one mRNA therapeutic from each of two new joint immuno-oncology programs. Moderna’s Onkaido Therapeutics LLC...
BioCentury | Jan 12, 2016
Company News

Moderna expands Merck, AZ partnerships

...on two immuno-oncology programs under a new agreement distinct from the companies' existing partnership. Moderna's Onkaido Therapeutics LLC...
BioCentury | Oct 16, 2015
Company News

Moderna CSO Bolen resigns

...CMO Tal Zaks and the CSOs of Moderna subsidiaries Elpidera LLC , Valera LLC and Onkaido Therapeutics LLC...
BioCentury | May 13, 2015
Company News

Moderna creates rare disease subsidiary Elpidera

...bacterial and parasitic infections. Last year, Moderna spun out 15 preclinical mRNA cancer therapeutics into Onkaido Therapeutics LLC...
BioCentury | Jan 12, 2015
Company News

Onkaido Therapeutics management update

Onkaido Therapeutics LLC , Cambridge, Mass. Business: Cancer Hired: Michael Morin as CSO, formerly VP of global R&D at Pfizer Inc. WIR Staff...
BioCentury | Jan 8, 2015
Product R&D

Shooting the messenger

...with Alexion Pharmaceuticals Inc. in 2014 for rare diseases. Also in 2014, Moderna spun out Onkaido Therapeutics LLC...
...ethris GmbH, Planegg, Germany Marina Biotech Inc. (OTCQB:MRNA), Bothell, Wash. Moderna Therapeutics Inc., Cambridge, Mass. Onkaido Therapeutics LLC...
BioCentury | Jan 6, 2015
Top Story

Crossover investors join Moderna's $450M round

...current team of 145. Last year, Moderna spun out 15 preclinical mRNA cancer therapeutics into Onkaido Therapeutics LLC...
Items per page:
1 - 10 of 16
BioCentury | Apr 27, 2018
Finance

Revolution revamp

...year, hired Stephen Kelsey as president of R&D. Kelsey was president of oncology mRNA play Onkaido Therapeutics LLC...
BioCentury | Sep 14, 2017
Company News

Moderna unveils organizational changes and new candidates

...heart failure patients undergoing coronary artery bypass grafting (CABG) surgery. Mary Romeo AZD-8601 mRNA-2416 Alexion Pharmaceuticals Inc. CRISPR Therapeutics AG Elpidera LLC Onkaido Therapeutics LLC Valera...
BioCentury | Mar 21, 2017
Company News

Management tracks

...Medicines Inc. (Redwood City, Calif.) named Stephen Kelsey president of R&D. Kelsey was president of Onkaido Therapeutics LLC...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, AstraZeneca deal

...develop and co-commercialize one mRNA therapeutic from each of two new joint immuno-oncology programs. Moderna’s Onkaido Therapeutics LLC...
BioCentury | Jan 12, 2016
Company News

Moderna expands Merck, AZ partnerships

...on two immuno-oncology programs under a new agreement distinct from the companies' existing partnership. Moderna's Onkaido Therapeutics LLC...
BioCentury | Oct 16, 2015
Company News

Moderna CSO Bolen resigns

...CMO Tal Zaks and the CSOs of Moderna subsidiaries Elpidera LLC , Valera LLC and Onkaido Therapeutics LLC...
BioCentury | May 13, 2015
Company News

Moderna creates rare disease subsidiary Elpidera

...bacterial and parasitic infections. Last year, Moderna spun out 15 preclinical mRNA cancer therapeutics into Onkaido Therapeutics LLC...
BioCentury | Jan 12, 2015
Company News

Onkaido Therapeutics management update

Onkaido Therapeutics LLC , Cambridge, Mass. Business: Cancer Hired: Michael Morin as CSO, formerly VP of global R&D at Pfizer Inc. WIR Staff...
BioCentury | Jan 8, 2015
Product R&D

Shooting the messenger

...with Alexion Pharmaceuticals Inc. in 2014 for rare diseases. Also in 2014, Moderna spun out Onkaido Therapeutics LLC...
...ethris GmbH, Planegg, Germany Marina Biotech Inc. (OTCQB:MRNA), Bothell, Wash. Moderna Therapeutics Inc., Cambridge, Mass. Onkaido Therapeutics LLC...
BioCentury | Jan 6, 2015
Top Story

Crossover investors join Moderna's $450M round

...current team of 145. Last year, Moderna spun out 15 preclinical mRNA cancer therapeutics into Onkaido Therapeutics LLC...
Items per page:
1 - 10 of 16